Prior to covid-19, it was the opioid epidemic that worried U.S. officials, with reports showing that the abuse of opioids nationwide was contributing to increased healthcare costs and overdose deaths. In 2020, however, things changed. With covid came lockdowns, and with the lockdowns came unemployment, isolation, and depression.  By early 2021, the Centers for...
Read More »

President Trump has tried seemingly everything to lower prescription drug prices. In 2018 alone, he established an international pricing index to prevent overcharging from foreign drug producers, targeted drug rebates between producers and middlemen, and granted Medicare Part D plans more authority to negotiate drug prices. Despite these and other efforts, the prices for thousands of...
Read More »

Having written critically about a decision made by Doctors Without Borders/Médecins Sans Frontières (MSF) to reject a donation of vaccines by Pfizer, Inc., I am grateful for a new report which ranks research-based pharmaceutical companies on a number of measurements of how they make medicines available to patients in low-income countries. Jointly funded by the...
Read More »